HC Wainwright Reiterates Buy on Cullinan Therapeutics With $35 Target
HC Wainwright & Co. reiterated a Buy rating on Cullinan Therapeutics (CGEM) with a price target of $35.00, implying a 140.9% upside from the previous close.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.